EYE » Topics » ITEM 2.02. Results of Operations and Financial Condition

This excerpt taken from the EYE 8-K filed Feb 20, 2009.

ITEM 2.02.  Results of Operations and Financial Condition

 

On February 20, 2009, the Company announced financial results for the quarter and year ended December 31, 2008.  A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference.  The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or Exchange Act.

 

This excerpt taken from the EYE 8-K filed Feb 13, 2007.

Item 2.02.              Results of Operations and Financial Condition

On February 13, 2007, Advanced Medical Optics, Inc. announced financial results for the quarter and year ended December 31, 2006.  A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference.  The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

This excerpt taken from the EYE 8-K filed Oct 26, 2006.

Item 2.02.              Results of Operations and Financial Condition

On October 26, 2006, Advanced Medical Optics, Inc. announced financial results for the quarter ended September 29, 2006.  A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference.  The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

This excerpt taken from the EYE 8-K filed Aug 1, 2006.

Item 2.02.              Results of Operations and Financial Condition

On August 1, 2006, Advanced Medical Optics, Inc. announced financial results for the quarter ended June 30, 2006.  A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference.  The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

This excerpt taken from the EYE 8-K filed Apr 27, 2006.
Results of Operations and Financial Condition

 

On April 27, 2006, Advanced Medical Optics, Inc. announced financial results for the quarter ended March 31, 2006. A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

 

This excerpt taken from the EYE 8-K filed Feb 14, 2006.

Item 2.02.              Results of Operations and Financial Condition

 

On February 14, 2006, Advanced Medical Optics, Inc. announced financial results for the quarter and year ended December 31, 2005. A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

 

This excerpt taken from the EYE 8-K filed Jul 20, 2005.

Item 2.02. Results of Operations and Financial Condition

 

On July 20, 2005, Advanced Medical Optics, Inc. announced financial results for the quarter ended June 24, 2005. A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

 

This excerpt taken from the EYE 8-K filed Jul 19, 2005.

Item 2.02 Results of Operations and Financial Condition.

 

On July 13, 2005, Advanced Medical Optics, Inc. reported certain pro forma financial information relating to its recent acquisition of VISX, Incorporated on May 27, 2005. Such pro forma financial information was included in Item 8.01 of AMO’s Current Report on Form 8-K dated and filed July 13, 2005, which by this reference is incorporated herein.

 

This excerpt taken from the EYE 8-K filed Apr 28, 2005.

Item 2.02. Results of Operations and Financial Condition

 

On April 28, 2005, Advanced Medical Optics, Inc. announced financial results for the quarter ended March 25, 2005. A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

 

This excerpt taken from the EYE 8-K filed Feb 8, 2005.

Item 2.02. Results of Operations and Financial Condition

 

On February 8, 2005, Advanced Medical Optics, Inc. announced financial results for the quarter and year ended December 31, 2004. A copy of the press release making this announcement is furnished as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

 

This excerpt taken from the EYE 8-K filed Jan 26, 2005.

Item 2.02. Results of Operations and Financial Condition.

On January 26, 2005, Advanced Medical Optics, Inc. issued a press release regarding preliminary unaudited results for the fourth quarter and year ended December 31, 2004. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference. In accordance with General Instructions B.2 of Form 8-K, the information in this Current Report on Form 8-K under Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.





Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki